Walmsley responds to GSK spin-off rumours

26 July 2018 - Deborah Wilkes


GlaxoSmithKline's board continues to believe that the company's current structure – based around Consumer Healthcare, Pharmaceuticals and Vaccines businesses – "offers significant opportunities in the current healthcare environment", according to chief executive officer Emma Walmsley.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: